TheraRadar
← Back
Data updated: Mar 29, 2026

QILU PHARM HAINAN

OncologyInfectious DiseaseCardiovascular
Generics

QILU PHARM HAINAN is a generic drug manufacturer focused on Oncology, Infectious Disease, Cardiovascular.

2014
Since
18
Drugs
-
Trials
143
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

MICAFUNGIN SODIUM 2026-02-24
BUMETANIDE 2026-02-05
CARBOPLATIN 2026-02-04
DOXORUBICIN HYDROCHLORIDE 2026-02-03
DAPTOMYCIN 2026-01-30
Labeling
DAPTOMYCIN 2026-01-26
Labeling
MICAFUNGIN SODIUM 2026-01-21
OXALIPLATIN 2026-01-15
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 40%
4 drugs
Infectious Disease 20%
2 drugs
Cardiovascular 20%
2 drugs
Dermatology 10%
1 drugs
Gastroenterology 10%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
CASPER PHARMA LLC big-pharma
Infectious Disease, Oncology, Cardiovascular, Gastroenterology, Dermatology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular